Edition:
United States

Erytech Pharma SA (ERYP.PA)

ERYP.PA on Paris Stock Exchange

16.45EUR
25 May 2018
Change (% chg)

€-0.18 (-1.08%)
Prev Close
€16.63
Open
€16.69
Day's High
€16.70
Day's Low
€16.29
Volume
14,162
Avg. Vol
28,002
52-wk High
€29.97
52-wk Low
€15.60

Chart for

About

Erytech Pharma SA, also known as ERYTECH Pharma, is a France-based biopharmaceutical company developing medicinal products mainly in oncology, hematology and immunology fields of business. The Company offers ESY-ASP (GRASPA), a medicinal product consisting of L-Asparaginase entrapped into human homologous red blood cells. The... (more)

Overall

Beta: 0.91
Market Cap(Mil.): €295.06
Shares Outstanding(Mil.): 17.94
Dividend: --
Yield (%): --

Financials

  ERYP.PA Industry Sector
P/E (TTM): -- 238.69 33.30
EPS (TTM): -2.94 -- --
ROI: -30.17 -7.54 13.04
ROE: -30.90 -10.33 14.90

BRIEF-Erytech To Present Results From Phase I Trial Of Eryaspase In All And New Pre Clinical Data At Aacr 2018

* ERYTECH TO PRESENT RESULTS FROM PHASE I TRIAL OF ERYASPASE IN ALL AND NEW PRE-CLINICAL DATA AT AACR 2018 Source text for Eikon: Further company coverage:

Apr 12 2018

BRIEF-Oncodesign Concludes A Partnership With Erytech In Oncology

* ONCODESIGN CONCLUDES A LONG TERM SERVICE-BASED PARTNERSHIP WITH ERYTECH IN ONCOLOGY

Mar 27 2018

BRIEF-Erytech FY Net Loss Widens To 33.5 Million Euros

* REPORTED ON MONDAY FY NET LOSS 33.5 MILLION EUROS, COMPARED TO 21.9 MILLION EUROS IN 2016

Mar 13 2018

Earnings vs. Estimates